Zonare experiences significant growth in vascular ultrasound market

Mt. View, Calif. – April 30, 2013 - ZONARE Medical Systems, the pioneer and developer of next generation ultrasound technology, is experiencing significant growth in the expanding vascular healthcare market with several customers purchasing additional ZONARE systems to support practice growth. The Scarless VeinCare group in North Carolina just added several more systems to its growing family of ZONARE systems.

“Our practice just added another three ZONARE z.one ultra systems for a total of eight units,” said Kamran Goudarzi, MD, founder and CEO of Scarless VeinCare, “With four very active vein centers in the area, we are committed to providing our patients with cutting-edge imaging technology. We are considered a vein center of excellence and ZONARE technology enables us to continue this designation, supporting our goal of offering state-of-the-art patient care.”

ZONARE’s Living Technology delivers ultrasound imaging excellence based on a dynamic and open architecture that allows continual platform evolvement to meet the changing needs of clinicians. ZONE Sonography technology is an innovative approach to echo data acquisition and image formation. Using a small number of large "zones," ZST acquires ultrasound data up to ten times faster than conventional systems and implements the full reality of data acquisition and management in software rather than hardware.

All ZONARE ultrasound systems offer a wide variety of transducer options with more under development as the technology continues to grow. Most transducers also are compatible with the ZS3, z.one ultra and z.one ultra sp systems as part of the ZONARE family of ZST products. In addition, each system is designed to receive software upgrades as ZST evolves.

“We have found the ability to upgrade our ZONARE systems to be a significantly solid investment for us,” said Andy Chiou, MD, CEO of Peoria Surgical Group in Illinois, who has purchased eight z.one systems. “We are also impressed by the upgrade path offered to the new ZS3 system which will add enhanced image quality economically, providing yet another advance in our healthcare offerings.”

About ZONARE Medical Systems, Inc.

 ZONARE Medical Systems, Inc., based in the United States’ Silicon Valley,  is solely dedicated to ultrasound excellence through its innovative, software-based, next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and architecture of the ZS3 and z.one ultra ultrasound platforms deliver high-end image quality and clinical versatility at unparalleled value. All ZONARE ultrasound systems are made in the USA. ZONARE’s exclusive, next generation ultrasound focus resulted in Frost & Sullivan awarding the 2011 North American Technology Innovation Award in Diagnostic Ultrasound Imaging Technology to ZONARE. For more information, visit: www.zonare.com.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.